Budpak Anti-itch
NDC Package 27293-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Budpak Anti-itch is usesfor the temporary relief of itching associated with minor skin irritations and rashes due to:eczemaseborrheic dermatitispsoriasisinsect bitespoison ivy, oak, sumacsoapsdetergentscosmeticsjewelryexternal genital, feminine and anal itchingOther uses or the use of the product for more than 7 days should be undertaken only under the advice and supervision of a doctor. Marketed by Budpak Inc., this product is identified by NDC 27293-017 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
27293-017-01
Package Description
1 TUBE in 1 BOX / 14 g in 1 TUBE (27293-017-14)
Product Code
27293-017
11-Digit Billing Format
27293001701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Budpak Anti-itch
Dosage Form
-
Usage Information
Usesfor the temporary relief of itching associated with minor skin irritations and rashes due to:eczemaseborrheic dermatitispsoriasisinsect bitespoison ivy, oak, sumacsoapsdetergentscosmeticsjewelryexternal genital, feminine and anal itchingOther uses or the use of the product for more than 7 days should be undertaken only under the advice and supervision of a doctor.

Regulatory & Marketing

Labeler Name
Budpak Inc.
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
12-17-2012
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27293-017-01 identifies a specific commercial package of 1 tube in 1 box / 14 g in 1 tube (27293-017-14) of Budpak Anti-itch, labeled by Budpak Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Budpak Inc. on December 17, 2012. The current certification is valid through December 31, 2019.

How is this Budpak Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27293001701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27293-017-01
11-Digit CMS (5-4-2)
27293-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.